VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F950. A total of 9 filers reported holding VERTEX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,489,342 | +256.8% | 73,300 | +261.1% | 0.01% | +300.0% |
| Q2 2023 | $7,143,773 | -58.9% | 20,300 | -63.2% | 0.00% | -71.4% |
| Q1 2023 | $17,391,864 | -42.2% | 55,200 | -47.0% | 0.01% | -50.0% |
| Q4 2022 | $30,090,876 | -26.1% | 104,200 | -25.9% | 0.01% | -22.2% |
| Q3 2022 | $40,738,000 | -10.5% | 140,700 | -12.9% | 0.02% | -5.3% |
| Q2 2022 | $45,509,000 | – | 161,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 163,900 | $35,992,000 | 0.03% |
| SIMPLEX TRADING, LLC | 85,900 | $18,863,000 | 0.02% |
| SG Americas Securities, LLC | 100,000 | $510,000 | 0.00% |
| IMC-Chicago, LLC | 10,700 | $2,350,000 | 0.00% |
| JPMORGAN CHASE & CO | 39,100 | $8,586,000 | 0.00% |
| Allianz Asset Management GmbH | 6,000 | $1,318,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |